Vanda Pharmaceuticals Inc. · NASDAQ:VNDA
State Street Corp reported a 5.10% stake in Vanda Pharmaceuticals Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp reported a 5.10% stake in Vanda Pharmaceuticals Inc., 3,015,562 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 3,015,562
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.10% | 3,015,562 |
Source
Related
- Vanda Pharmaceuticals Inc.
- State Street Corp
- Vanda Pharmaceuticals Inc. shareholders
- Schedule 13G/A · Millennium Management LLC · Oct 9, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G · AQR Capital Management LLC · Aug 13, 2026
- Form 4 · McGuire Daniel Patrick · Jun 8, 2026
- Form 4 · Chrousos Phaedra · Jun 8, 2026